Back to Agenda
Should a COVID-19 Vaccination be Legally Mandated and Can HTA Inform That Decision?
Session Chair(s)
Richard Hiraiwa Stanford, PharmD, MS
Vice President, Strategic Consulting
AESARA, United States
Health Technology Assessment (HTA) is defined as a multidisciplinary process to evaluate the social, economic, organizational and ethical issues of an intervention or health technology. In anticipation of COVID-19 vaccine, a panel composed of the relevant stakeholders will have an open dialogue about the role of HTA in informing public health policy-making, with particular focus on vaccination, and enforcing such policies at an individual country and global levels. Potential learnings from previous pandemics, such as H1N1, will be reviewed. Ethical and economic challenges will be debated to offer a consensus position that takes into account societal benefits, economic, logistical and legal considerations.
Learning Objective : Debate the ethical, logistical, and legal implications if a mandated vaccine program were to be instituted and what would inform such a decision; Discuss the role and opportunity of HTA to inform and recommend a decision.
Speaker(s)
Panelist
Richard Hiraiwa Stanford, PharmD, MS
AESARA, United States
Vice President, Strategic Consulting
Panelist
Phil Ball, PhD
Independent Consultant, United States
Health Policy, Biopharmaceutical Development Strategy
Panelist
Andrew H. Briggs, PhD, MSc
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
Professor of Health Economics
Have an account?